Production value of antineoplastics Japan 2015, by category

The statistic shows the drug production value of antineoplastics in Japan in 2015, broken down by sub therapeutic category. In 2015, the production value of antimetabolites made up the largest share with approximately 35 billion Japanese yen, followed by antitumor plant extract preparations with a production value of around 18 billion yen.

本统计数据显示了2015年日本抗肿瘤药物生产值，按照亚治疗类别进行细分。在2015年，抗代谢药物的生产值占据了最大的份额，约为350亿日元，紧随其后的是抗肿瘤植物提取物制剂，其生产值约为180亿日元。